134 related articles for article (PubMed ID: 14695223)
1. Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopy.
Zakian KL; Shukla-Dave A; Meyers P; Gorlick R; Healey J; Thaler HT; Huvos AG; Panicek DM; Koutcher JA
Cancer Res; 2003 Dec; 63(24):9042-7. PubMed ID: 14695223
[TBL] [Abstract][Full Text] [Related]
2. [Changes of 3-tesla 31P-MR spectroscopy of bone and soft tissue tumors].
Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):442-6. PubMed ID: 19950555
[TBL] [Abstract][Full Text] [Related]
3. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
4. Metabolic characterization of human soft tissue sarcomas in vivo and in vitro using proton-decoupled phosphorus magnetic resonance spectroscopy.
Li CW; Kuesel AC; Padavic-Shaller KA; Murphy-Boesch J; Eisenberg BL; Schmidt RG; von Roemeling RW; Patchefsky AS; Brown TR; Negendank WG
Cancer Res; 1996 Jul; 56(13):2964-72. PubMed ID: 8674050
[TBL] [Abstract][Full Text] [Related]
5. Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy.
Negendank WG; Padavic-Shaller KA; Li CW; Murphy-Boesch J; Stoyanova R; Krigel RL; Schilder RJ; Smith MR; Brown TR
Cancer Res; 1995 Aug; 55(15):3286-94. PubMed ID: 7614463
[TBL] [Abstract][Full Text] [Related]
6. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy.
Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971
[TBL] [Abstract][Full Text] [Related]
7. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
[TBL] [Abstract][Full Text] [Related]
8. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers.
Marcus KJ; Astrakas LG; Zurakowski D; Zarifi MK; Mintzopoulos D; Poussaint TY; Anthony DC; De Girolami U; Black PM; Tarbell NJ; Tzika AA
Int J Oncol; 2007 Mar; 30(3):651-7. PubMed ID: 17273766
[TBL] [Abstract][Full Text] [Related]
9. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor.
Oya N; Aoki J; Shinozaki T; Watanabe H; Takagishi K; Endo K
Radiat Med; 2000; 18(3):193-8. PubMed ID: 10972550
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.
Endo M; Tateishi U; Seki K; Yamaguchi U; Nakatani F; Kawai A; Chuman H; Beppu Y
Jpn J Clin Oncol; 2007 Dec; 37(12):955-60. PubMed ID: 18211986
[TBL] [Abstract][Full Text] [Related]
11. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
Winter PM; Poptani H; Bansal N
Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759
[TBL] [Abstract][Full Text] [Related]
12. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
[TBL] [Abstract][Full Text] [Related]
13. A general aspect on soft-tissue sarcoma and c-kit expression in primitive neuroectodermal tumor and Ewing's sarcoma. Is there any role in disease process?
Kara IO; Gonlusen G; Sahin B; Ergin M; Erdogan S
Saudi Med J; 2005 Aug; 26(8):1190-6. PubMed ID: 16127511
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
[TBL] [Abstract][Full Text] [Related]
15. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
Lucas DR; Kshirsagar MP; Biermann JS; Hamre MR; Thomas DG; Schuetze SM; Baker LH
Oncologist; 2008 Apr; 13(4):451-8. PubMed ID: 18448561
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla.
Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C
Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
Laprie A; Catalaa I; Cassol E; McKnight TR; Berchery D; Marre D; Bachaud JM; Berry I; Moyal EC
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):773-81. PubMed ID: 18262090
[TBL] [Abstract][Full Text] [Related]
19. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
